Kwality Pharmaceuticals
KPLBSE

Kwality Pharmaceuticals

₹1,424.050.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,335.55
Today’s high
1,430.00
52 week low
666.00
52 week high
1,740.00
Open price
1,371.00
Previous close
1,424.05
Live volume
--
Lower circuit
1,139.25
Upper circuit
1,708.85

Fundamentals

Market Cap
₹1,478Cr
ROE
16.91%
P/E Ratio(TTM)
26.14
EPS(TTM)
54.47
P/B Ratio
5.11
Dividend Yield
0.00%
Industry P/E
31.31
Book Value
278.82
Debt to Equity
0.38
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Established in 1983, Kwality Pharmaceuticals Limited is a prominent Indian pharmaceutical firm focused on providing high-quality medicines to the global market. The company's vision is to expand its global footprint by registering products in new emerging markets and forming strategic partnerships with international companies. Its mission revolves around manufacturing excellence, using robust quality control systems to consistently ensure the safety and efficacy of its products. The firm's business model is predominantly focused on exports, which contribute to more than 95% of the company's revenues. It manufactures a diverse portfolio of over 3000 formulations, covering more than 25 therapeutic areas including oncology, biologics, and complex injectables. Demonstrating its growing global reach, the company exports to over 60 countries and has recently ventured into the Brazilian and EU markets.;
MD/CEO
Mr. Ramesh Arora
Founded in
1983
BSE symbol
539997
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
54.83%
Retail And Others
44.34%
Foreign Institutions
0.50%
Other Domestic Institutions
0.33%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹704.40
+0.45 (0.06%)
L
    H
    4,025.7730.43.94
    ₹388.25
    -4.50 (1.15%)
    L
      H
      3,640.7240.624.99
      Aarti DrugsAARTIDRUGS
      ₹352.70
      +6.30 (1.82%)
      L
        H
        3,213.1615.872.19
        ₹288.60
        -0.10 (0.03%)
        L
          H
          2,905.6958.074.6
          Livesquawk
          Kwaltiy Pharmaceuticals completes Phase 1 bioequivalence program; BE studies for Hydroxycarbamide, Nilotinib, Liposomal Amphotericin B done. Dossiers prepared for submission in regulated and semi-regulated markets.
          2026
          12
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          11
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks